Basic science behind the cardiovascular benefits of exercise

British Journal of Sports Medicine

Volumn 50, Issue 2, 2016, Pages 93-99

  Wilson, Mathew G ^a,b,c   Ellison, Georgina M ^d   Cable, N Tim ^b,e,f  

^a ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF CANBERRA   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ASPIRE Academy for Sports Excellence   (Qatar)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR; NITRIC OXIDE;

ADAPTATION; BIOSYNTHESIS; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; EXERCISE; HEART VENTRICLE REMODELING; HUMAN; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPORT; UPREGULATION; VASCULAR ENDOTHELIUM;

ADAPTATION, PHYSIOLOGICAL; CARDIOMEGALY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; ENDOTHELIUM, VASCULAR; EXERCISE; GROWTH SUBSTANCES; HUMANS; NITRIC OXIDE; OXYGEN CONSUMPTION; SPORTS; UP-REGULATION; VENTRICULAR REMODELING;

EID: 84954305606     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2014-306596rep     Document Type: Article

References (65)

1. Blair SN, Kohl HW III, Paffenbarger RS Jr, et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989;262:2395-401.
2. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009;301:2024-35.
3. Lee DC, Sui X, Artero EG, et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study. Circulation 2011;124:2483-90.
4. Marijon E, Tafflet M, Antero-Jacquemin J, et al. Mortality of French participants in the Tour de France (1947-2012). Eur Heart J 2013;34:3145-50.
5. Swedish National Institute of Public Health. Physical activity in the prevention and treatment of disease. Sweden, 2010. http://www.fyss.se/wp-content/uploads/2011/02/fyss-2010-english.pdf
6. Arbab-Zadeh A, Perhonen M, Howden E, et al. Cardiac remodeling in response to 1 year of intensive endurance training. Circulation 2014;130:2152-61.
7. Utomi V, Oxborough D, Whyte GP, et al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete's heart. Heart 2013;99:1727-33.
8. Scharhag J, Thunenkotter T, Urhausen A, et al. Echocardiography of the right ventricle in athlete's heart and hearts of normal size compared to magnetic resonance imaging: which measurements should be applied in athletes? Int J Sports Med 2010;31:58-64.
9. Wilson M, O'Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol 2011;110:1622-6.
10. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301.
11. Whyte GP, George K, Sharma S, et al. The upper limit of physiological cardiac hypertrophy in elite male and female athletes: the British experience. Eur J Appl Physiol 2004;92:592-7.
12. Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;51:2256-62.
13. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol 2008;51:1033-9.
14. Kemi OJ, Loennechen JP, Wisloff U, et al. Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy. J Appl Physiol (1985) 2002;93:1301-9.
15. Waring CD, Vicinanza C, Papalamprou A, et al. The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur Heart J 2014;35:2722-31.
16. Jin H, Yang R, Li W, et al. Effects of exercise training on cardiac function, gene expression, and apoptosis in rats. Am J Physiol Heart Circ Physiol 2000;279:H2994-3002.
17. Kwak HB, Song W, Lawler JM. Exercise training attenuates age-induced elevation in Bax/Bcl-2 ratio, apoptosis, and remodeling in the rat heart. FASEB J 2006;20:791-3.
18. Siu PM, Bryner RW, Martyn JK, et al. Apoptotic adaptations from exercise training in skeletal and cardiac muscles. FASEB J 2004;18:1150-2.
19. Bostrom P, Mann N, Wu J, et al. C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010;143:1072-83.
20. Ellison GM, Waring CD, Vicinanza C, et al. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart 2012;98:5-10.
21. White FC, Bloor CM, McKirnan MD, et al. Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol (1985) 1998;85:1160-8.
22. Thijssen DH, Torella D, Hopman MT, et al. The role of endothelial progenitor and cardiac stem cells in the cardiovascular adaptations to age and exercise. Front Biosci (Landmark Ed) 2009;14:4685-702.
23. Weeks KL and McMullen JR. The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes? Physiology (Bethesda) 2011;26:97-105.
24. Opie LH, Commerford PJ, Gersh BJ, et al. Controversies in ventricular remodelling. Lancet 2006;367:356-67.
25. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102.
26. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
27. Ellison GM, Vicinanza C, Smith AJ, et al. Adult c-kit (pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013;154:827-42.
28. Neri Serneri GG, Boddi M, Modesti PA, et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 2001;89:977-82.
29. McMullen JR, Shioi T, Huang WY, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110alpha) pathway. J Biol Chem 2004;279:4782-93.
30. Luo J, McMullen JR, Sobkiw CL, et al. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 2005;25:9491-502.
31. Kim J, Wende AR, Sena S, et al. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol 2008;22:2531-43.
32. McMullen JR, Amirahmadi F, Woodcock EA, et al. Protective effects of exercise and phosphoinositide 3-kinase (p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 2007;104:612-7.
33. De Bosch B, Treskov I, Lupu TS, et al. Akt1 is required for physiological cardiac growth. Circulation 2006;113:2097-104.
34. Shiraishi I, Melendez J, Ahn Y, et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res 2004;94:884-91.
35. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004;94:514-24.
36. Fischer KM, Din S, Gude N, et al. Cardiac progenitor cell commitment is inhibited by nuclear Akt expression. Circ Res 2011;108:960-70.
37. Yasuda S, Goto Y, Takaki H, et al. Exercise-induced hepatocyte growth factor production in patients after acute myocardial infarction: its relationship to exercise capacity and brain natriuretic peptide levels. Circ J 2004;68:304-7.
38. Laufs U, Werner N, Link A, et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004;109:220-6.
39. Gustafsson T, Rundqvist H, Norrbom J, et al. The influence of physical training on the angiopoietin and VEGF-A systems in human skeletal muscle. J Appl Physiol (1985) 2007;103:1012-20.
40. Czarkowska-Paczek B, Bartlomiejczyk I, Przybylski J. The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise. J Physiol Pharmacol 2006;57:189-97.
41. Rastaldo R, Pagliaro P, Cappello S, et al. Nitric oxide and cardiac function. Life Sci 2007;81:779-93.
42. Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol 2011;58:977-86.
43. Santini MP, Tsao L, Monassier L, et al. Enhancing repair of the mammalian heart. Circ Res 2007;100:1732-40.
44. Jin RC, Loscalzo J. Vascular Nitric Oxide: Formation and Function. J Blood Med 2010;2010:147-62.
45. Green DJ, O'Driscoll G, Joyner MJ, et al. Exercise and cardiovascular risk reduction: time to update the rationale for exercise? J Appl Physiol (1985) 2008;105:766-8.
46. Doshi SN, Naka KK, Payne N, et al. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond) 2001;101:629-35.
47. Goto C, Higashi Y, Kimura M, et al. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003;108:530-5.
48. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51.
49. Birk GK, Dawson EA, Atkinson C, et al. Brachial artery adaptation to lower limb exercise training: role of shear stress. J Appl Physiol (1985) 2012;112:1653-8.
50. Green DJ, Spence A, Halliwill JR, et al. Exercise and vascular adaptation in asymptomatic humans. Exp Physiol 2011;96:57-70.
51. Thijssen DH, Maiorana AJ, O'Driscoll G, et al. Impact of inactivity and exercise on the vasculature in humans. Eur J Appl Physiol 2010;108:845-75.
52. Dawson EA, Whyte GP, Black MA, et al. Changes in vascular and cardiac function after prolonged strenuous exercise in humans. J Appl Physiol (1985) 2008;105:1562-8.
53. Tinken TM, Thijssen DH, Black MA, et al. Time course of change in vasodilator function and capacity in response to exercise training in humans. J Physiol 2008;586(Pt 20):5003-12.
54. Rowley NJ, Dawson EA, Birk GK, et al. Exercise and arterial adaptation in humans: uncoupling localized and systemic effects. J Appl Physiol (1985) 2011;110:1190-5.
55. Tinken TM, Thijssen DH, Hopkins N, et al. Shear stress mediates endothelial adaptations to exercise training in humans. Hypertension 2010;55:312-18.
56. Newcomer SC, Thijssen DH, Green DJ. Effects of exercise on endothelium and endothelium/smooth muscle cross talk: role of exercise-induced hemodynamics. J Appl Physiol (1985) 2011;111:311-20.
57. Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee Report. Washington DC: US Department of Health and Human Services, 2008. http://www.health.gov/paguidelines/Report/pdf/CommitteeReport.pdf
58. Powell KE, Paluch AE, Blair SN. Physical activity for health: What kind? How much? How intense? On top of what? Annu Rev Public Health 2011;32:349-65.
59. Bhella PS, Hastings JL, Fujimoto N, et al. Impact of lifelong exercise "dose" on left ventricular compliance and distensibility. J Am Coll Cardiol 2014;64:1257-66.
60. Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med 2014;48:1227-34.
61. Weston M, Taylor KL, Batterham AM, et al. Effects of low-volume high-intensity interval training (HIT) on fitness in adults: a meta-analysis of controlled and non-controlled trials. Sports Med 2014;44:1005-17.
62. Angadi SS, Mookadam F, Lee CD, et al. High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study. J Appl Physiol (1985) 2014: jap 00518.2014.
63. Lee DC, Artero EG, Sui X, et al. Mortality trends in the general population: the importance of cardiorespiratory fitness. J Psychopharmacol 2010;24(4 Suppl):27-35.
64. Green DJ, Spence A, Rowley N, et al. Vascular adaptation in athletes: is there an 'athlete's artery'? Exp Physiol 2012;97:295-304.
65. Bernardo BC, Weeks KL, Pretorius L, et al. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 2010;128:191-227.